Viewing Study NCT00513604

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:59 PM
Ignite Modification Date: 2026-03-06 @ 5:27 PM
Study NCT ID: NCT00513604
Status: COMPLETED
Last Update Posted: 2013-06-03
First Post: 2007-08-06
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Phase II Study of Short-Term Cultured Anti-Tumor Autologous Lymphocytes After Lymphocyte-Depleting Chemotherapy in Metastatic Melanoma
Sponsor: National Cancer Institute (NCI)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Melanoma View
None Malignant Melanoma View
None Melanoma, Experimental View
None Experimental Melanomas View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Clinical Response View
None Immunotherapy View
None Cancer View
None Cytokines View
None Adoptive Cell Therapy View
None Melanoma View
None Skin Cancer View
None Malignant Melanoma View